AdaptHealth (AHCO) Stock Forecast & Price Target

Compare

326 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

AHCO Analyst Ratings

Strong Buy

3 Buy

1 Hold

0 Sell

Based on 4 analysts giving stock ratings to

AdaptHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

AHCO Stock 12 Month Forecast

Average Price Target

$12.38

▲(36.34% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for AdaptHealth in the last 3 months. The average price target is $12.38 with a high forecast of $14.00 and a low forecast of $9.50. The average price target represents a 36.34% change from the last price of $9.08.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","9":"$9","11":"$11","13":"$13","15":"$15"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$14.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$12.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,9,11,13,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.1,10.4,10.7,11,11.3,11.6,11.9,12.2,12.5,12.8,13.1,13.4,13.7,{"y":14,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.1,10.275384615384615,10.45076923076923,10.626153846153846,10.801538461538462,10.976923076923077,11.152307692307692,11.327692307692308,11.503076923076923,11.678461538461539,11.853846153846154,12.02923076923077,12.204615384615385,{"y":12.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.1,10.053846153846154,10.007692307692308,9.961538461538462,9.915384615384616,9.86923076923077,9.823076923076924,9.776923076923076,9.73076923076923,9.684615384615384,9.638461538461538,9.592307692307692,9.546153846153846,{"y":9.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.52,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.82,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.38,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.82,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.15,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.11,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 53, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.99,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 49, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 71, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$14.00

Average Price Target$12.38

Lowest Price Target$9.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David S Macdonald

Truist Financial

$13

Buy

43.17%

Upside

Reiterated

02/25/26

AdaptHealth (AHCO) Gets a Buy from Truist Financial

Richard Close

Canaccord Genuity

$15→$14

Buy

54.19%

Upside

Reiterated

02/25/26

AdaptHealth price target lowered to $14 from $15 at CanaccordAdaptHealth price target lowered to $14 from $15 at Canaccord

Pito Chickering

Deutsche Bank

$10.5→$9.5

Hold

4.63%

Upside

Reiterated

02/25/26

AdaptHealth price target lowered to $9.50 from $10.50 at Deutsche BankAdaptHealth price target lowered to $9.50 from $10.50 at Deutsche Bank

Ben Hendrix

RBC Capital

$13

Buy

43.17%

Upside

Reiterated

02/24/26

RBC Capital Keeps Their Buy Rating on AdaptHealth (AHCO)

Whit Mayo

Leerink Partners

$13

Buy

43.17%

Upside

Reiterated

08/13/25

AdaptHealth's Positive Trajectory and Strategic Growth Support Buy Rating

Kevin Caliendo

UBS

$14→$15

Buy

65.20%

Upside

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM), Prestige Consumer Healthcare (NYSE: PBH) and AdaptHealth (NASDAQ: AHCO)

Brian Tanquilut

Jefferies

$10.5

Hold

15.64%

Upside

Reiterated

07/21/25

Jefferies Sticks to Its Hold Rating for AdaptHealth (AHCO)

Eric Coldwell

Robert W. Baird

$14→$16

Buy

76.21%

Upside

Reiterated

02/27/25

AdaptHealth price target raised to $16 from $14 at BairdAdaptHealth price target raised to $16 from $14 at Baird

Mathew Blackman

TD Cowen

$11

Hold

21.15%

Upside

Reiterated

02/27/25

Stifel Nicolaus Reaffirms Their Hold Rating on AdaptHealth (AHCO)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David S Macdonald

Truist Financial

$13

Buy

43.17%

Upside

Reiterated

02/25/26

AdaptHealth (AHCO) Gets a Buy from Truist Financial

Richard Close

Canaccord Genuity

$15→$14

Buy

54.19%

Upside

Reiterated

02/25/26

AdaptHealth price target lowered to $14 from $15 at CanaccordAdaptHealth price target lowered to $14 from $15 at Canaccord

Pito Chickering

Deutsche Bank

$10.5→$9.5

Hold

4.63%

Upside

Reiterated

02/25/26

AdaptHealth price target lowered to $9.50 from $10.50 at Deutsche BankAdaptHealth price target lowered to $9.50 from $10.50 at Deutsche Bank

Ben Hendrix

RBC Capital

$13

Buy

43.17%

Upside

Reiterated

02/24/26

RBC Capital Keeps Their Buy Rating on AdaptHealth (AHCO)

Whit Mayo

Leerink Partners

$13

Buy

43.17%

Upside

Reiterated

08/13/25

AdaptHealth's Positive Trajectory and Strategic Growth Support Buy Rating

Kevin Caliendo

UBS

$14→$15

Buy

65.20%

Upside

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM), Prestige Consumer Healthcare (NYSE: PBH) and AdaptHealth (NASDAQ: AHCO)

Brian Tanquilut

Jefferies

$10.5

Hold

15.64%

Upside

Reiterated

07/21/25

Jefferies Sticks to Its Hold Rating for AdaptHealth (AHCO)

Eric Coldwell

Robert W. Baird

$14→$16

Buy

76.21%

Upside

Reiterated

02/27/25

AdaptHealth price target raised to $16 from $14 at BairdAdaptHealth price target raised to $16 from $14 at Baird

Mathew Blackman

TD Cowen

$11

Hold

21.15%

Upside

Reiterated

02/27/25

Stifel Nicolaus Reaffirms Their Hold Rating on AdaptHealth (AHCO)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AdaptHealth

3 Months

xxx

Success Rate

13/24 ratings generated profit

Average Return

+3.85%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +3.85% per trade.

1 Year

Richard CloseCanaccord Genuity

Success Rate

10/24 ratings generated profit

Average Return

-12.18%

reiterated a buy rating 3 days ago

Copying Richard Close's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of -12.18% per trade.

2 Years

xxx

Success Rate

10/24 ratings generated profit

Average Return

-15.05%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -15.05% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AHCO Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, AHCO has received 15 Buy Ratings, 71 Hold Ratings, and 0 Sell Ratings. AHCO average Analyst price target in the past 3 months is 12.38.

Each month's total comprises the sum of three months' worth of ratings.

AHCO Financial Forecast

AHCO Earnings Forecast

Next quarter’s earnings estimate for AHCO is $0.01 with a range of -$0.02 to $0.05. The previous quarter’s EPS was $0.23. AHCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year AHCO has Performed in-line its overall industry.

AHCO Sales Forecast

Next quarter’s sales forecast for AHCO is $796.63M with a range of $793.72M to $799.00M. The previous quarter’s sales results were $846.29M. AHCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year AHCO has Performed in-line its overall industry.

AHCO Stock Forecast FAQ

What is AHCO’s average 12-month price target, according to analysts?

Based on analyst ratings, AdaptHealth’s 12-month average price target is 12.38.

What is AHCO’s upside potential, based on the analysts’ average price target?

AdaptHealth has 36.34% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is AHCO a Buy, Sell or Hold?

AdaptHealth has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.

What is AdaptHealth’s price target?

The average price target for AdaptHealth is 12.38. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $9.50. The average price target represents 36.34% Increase from the current price of $9.08.

What do analysts say about AdaptHealth?

AdaptHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of AHCO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

AdaptHealth (AHCO) Stock Forecast & Price Target

AHCO Analyst Ratings

AHCO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering AdaptHealth

AHCO Analyst Recommendation Trends

AHCO Financial Forecast

AHCO Earnings Forecast

AHCO Sales Forecast

AHCO Stock Forecast FAQ

Detailed List of Analyst Forecasts